ASCO study...Celgene

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

bfw

Rank: Vice President [?]

Points: 840 [?]

Votes: 19 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

ASCO study...Celgene

posted on Jun 01, 2019 10:48AM

https://abstracts.asco.org/239/AbstView_239_262531.html

Bfw

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply